Research Centre for the Study of Periodontal and Peri-Implant Diseases, University of Ferrara, Ferrara, Italy.
Operative Unit of Dentistry, University-Hospital of Ferrara, Ferrara, Italy.
Clin Oral Implants Res. 2020 Feb;31(2):105-120. doi: 10.1111/clr.13541. Epub 2019 Sep 30.
To evaluate the impact on peri-implant bone support (as assessed on periapical radiographs) of the remodeling dynamics of varying graft biomaterials used for transcrestal sinus floor elevation (tSFE).
The study is a multicenter, retrospective series of cases undergone tSFE (performed according to the Smart Lift technique) and concomitant implant placement. At operator's discretion, tSFE was performed with bone core (BC) alone or supplemented by deproteinized bovine or porcine bone mineral (DBBM and DPBM, respectively), synthetic hydroxyapatite in a collagen matrix (S-HA), or ß-tricalcium phosphate (ß-TCP). Immediately after surgery, at 6-12 months post-surgery, and at later (≥24 months) follow-up intervals, the percentage proportion of the implant surface in direct contact with the radiopaque area was calculated for the entire implant surface (totCON%). Also, the height of the graft apical to the implant apex (aGH) was assessed.
At 6-12 months following tSFE, median totCON% was 100%, with a median aGH of 1.4 mm. A tendency of aGH to decrease in height was observed at later follow-up intervals for sites treated with all grafting procedures. In all treatment groups, the majority of the implant surface was still surrounded by the radiopaque area at the longest follow-up visits.
Although the height of the peri-implant radiopaque area apical to the implant apex tends to reduce overtime at sites which have received tSFE, the peri-implant bone support seems to be maintained long term irrespective of the graft material used.
评估用于经牙槽嵴窦底提升术(tSFE)的不同移植物生物材料的重塑动力学对种植体周围骨支持(通过根尖片评估)的影响。
这是一项多中心、回顾性病例系列研究,对象接受了 tSFE(根据 Smart Lift 技术进行)和同期种植体植入。根据术者的判断,tSFE 单独使用骨芯(BC)或补充脱蛋白牛或猪骨矿物质(DBBM 和 DPBM)、胶原基质中的合成羟磷灰石(S-HA)或 β-磷酸三钙(β-TCP)。在手术后立即、术后 6-12 个月和后期(≥24 个月)随访期间,计算整个种植体表面与不透射线区域直接接触的种植体表面比例(totCON%)。同时评估种植体根尖上方移植物的高度(aGH)。
tSFE 后 6-12 个月,中位 totCON%为 100%,中位 aGH 为 1.4mm。在后期随访中,所有处理部位的 aGH 均有降低的趋势。在所有治疗组中,在最长的随访中,大多数种植体表面仍被不透射线区域包围。
尽管接受 tSFE 的部位种植体根尖上方的放射状骨高度随着时间的推移有降低的趋势,但无论使用何种移植物材料,种植体周围的骨支持似乎都能长期维持。